Free Trial
NASDAQ:DMAA

Drugs Made In America Acquisition (DMAA) Stock Price, News & Analysis

$10.29 +0.03 (+0.29%)
As of 09:32 AM Eastern

About Drugs Made In America Acquisition Stock (NASDAQ:DMAA)

Key Stats

Today's Range
$10.29
$10.29
50-Day Range
N/A
52-Week Range
$9.95
$10.29
Volume
101 shs
Average Volume
94,071 shs
Market Capitalization
$300.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DMAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Drugs Made In America Acquisition and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DMAA Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

DMAA Stock Analysis - Frequently Asked Questions

Drugs Made In America Acquisition's stock was trading at $10.26 at the beginning of the year. Since then, DMAA shares have increased by 0.3% and is now trading at $10.29.

Drugs Made In America Acquisition's top institutional investors include Karpus Management Inc. (9.41%), Wolverine Asset Management LLC (3.50%), Boothbay Fund Management LLC (1.95%) and AQR Arbitrage LLC (1.29%).

Shares of DMAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
9/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Investment Offices
Sub-Industry
Trading
Current Symbol
NASDAQ:DMAA
CIK
2028614
Web
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
29,171,000
Free Float
N/A
Market Cap
$300.17 million
Optionable
N/A
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:DMAA) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners